Fresh Human & Animal Hepatocytes

Fresh Human & Animal Hepatocytes

Fresh Plated Hepatocytes

Key Features of Human & Animal Fresh-Plated Hepatocytes:

  • Multi-format plated cells and custom preparation are available
  • Greater viability and confluence of cells in monolayer
  • High expression levels of major hepatic drug-metabolising enzymes, co-factors and cell membrane receptors
  • Greater flexibility for applications with either short or long-term cultures for human hepatocytes and cells derived from multiple animal species, either single or pooled donors
  • Full characterisation data available for each product batch sheet
  • Certificate of Analysis available for each batch
  • General patient information (age, gender, race, health conditions, serology)

Fresh-Plated Human Hepatocytes

To provide adherent monolayer cultures, Biopredic plates freshly isolated and viable cells, at a desired seeding density, onto collagen-coated culture supports according to the customer’s request/ordering.

After overnight attachment, the seeding medium is replaced with either a short-term culture medium or long-term culture medium (Lanford et al., 1989) to produce short-term (≤ 3 days) or long-term hepatocytes (≤ 6 days) cultures in which cells retain a differentiated phenotype for at least 1 week.

Both freshly prepared short-term and long-term cultured hepatocytes contain all major phase I and phase II enzymes as well as the whole gene regulation pathway necessary to investigate the potentiality of drugs to induce phase I and phase II enzymes.

Characteristics for Fresh-Plated Human Hepatocytes

  • Cell viability and cell culture period after isolation and seeding
  • Cell morphology and culture confluence by microphotography
  • Phase I drug-metabolising enzymes with a cocktail of probe substrates: CYP1A2/ 3A4/ 2B6/ 2D6/ 2C19
  • Phase II drug-metabolising enzymes: UGT1A1/ UGT1A6/ UGT1A9/ UGT2B15/ SULT1A1/ SULT1A3/ 4/ SULT1E1
  • Serological and sterility control data

Fresh-Plated Animal Hepatocytes

To provide plated animal hepatocyte cultures, the freshly isolated and viable cells are plated at a desired seeding density onto a collagen-coated culture surface according to the customer’s request/order.

After an appropriate period of cell attachment (from 4 hours to overnight depending upon the species), the seeding medium is replaced with a short-term culture medium and then packaged for shipment.

Fresh-plated cultured hepatocytes contain all major phase I and phase II enzymes and can be used in a wide range of in-vitro applications.

Characteristics for Fresh-Plated Human Hepatocytes

  • Donor animal information (species, identification number, age, sex, serology)
  • Viability, yield, plateability, and morphology before and after shipment
  • Phase I drug-metabolising enzymes with either a cocktail of probe substrates or a specific probe substrate: CYP1A/ CYP2D/ CYP3A
  • Phase II drug-metabolising enzymes: UGT1A/ UGT2B/ SULT1A/SULT1E. 
  • Glucuronidation and sulfation activity of acetaminophen
  • Sterility control data

Fresh Hepatocytes in Suspension

In order to provide suspended human & animal hepatocytes, freshly isolated hepatocytes are rapidly suspended and preserved in Biopredic’s optimised hypothermic medium to maintain cell viability and functional activity during the shipment period (up to 48 hours).

Fresh Human Hepatocytes in Suspension

Key Features of Fresh Human Hepatocytes in Suspension:

  • Good availability of fresh cells with a proprietary production process
  • High-quality products combined with optimised hypothermic shipping conditions
  • Stable and retained viability and expression level of metabolising enzymes
  • Greater flexibility to handle cells either in suspension or plated cell culture
  • Characterisation data available for each product batch sheet
    • Viability after isolation and after the cold shipping period, yield & plateability after the cold storage period, morphology before and after shipment
    • Phase I drug-metabolising enzymes with a cocktail of probe substrates: CYP1A2/ 3A4/ 2B6/ 2D6/ 2C19
    • Phase II drug-metabolising enzymes: UGT1A1/ UGT1A6/ UGT1A9/ UGT2B15/ SULT1A1/ SULT1A3/ 4/ SULT1E1
    • Serological and sterility control data
  • General patient information (age, gender, race, health conditions, serology)

Fresh Animal Hepatocytes in Suspension

Key Features of Fresh Animal Hepatocytes in Suspension:

  • Good availability of fresh cells from multiple species thanks to our scheduled production
  • Custom preparation are available for both single-donor and pooled cells
  • Large pooled lot size allows for conducting multiple experiments from the same pool of donors.
  • High-quality product combined with optimised hypothermic shipping conditions
  • Stable and retained viability and expression level of metabolizing enzymes,
  • Greater flexibility to handle cells either in suspension or plated cell culture
  • Certificate of Analysis available for each batch
  • Characterisation data available for each product batch sheet
    • Donor animal information (species, identification number, age, sex, serology)
    • Viability, yield, plateability, and morphology before and after shipment
    • Phase I drug-metabolising enzymes with either a cocktail of probe substrates or a specific probe substrate: CYP1A/ CYP2D/ CYP3A
    • Phase II drug-metabolising enzymes: UGT1A/ UGT2B/ SULT1A/SULT1E. 
    • Glucuronidation and sulfation activity of acetaminophen
    • Sterility control data

Caltag Medsystems is the distributor of Biopredic International products in the UK and Europe. If you have any questions about these products, please contact us.

Fresh Human & Animal Hepatocytes
Tagged on:             

Contact us